Table 2.
Laboratory test results for COVID-19 positive group compared with the control group.
| Test | COVID-19 Group * (n = 103) |
Control Group * (n = 50) |
p-Value |
|---|---|---|---|
| ACE2 (U/L) | 72.37 ± 18.67 | 32.36 ± 11.27 | ≤0.001 (HS) |
| IL-6 (pg/mL) | 95.84 ± 25.23 | 2.76 ± 0.62 | ≤0.001 (HS) |
| Glucose (mg/dL) | 188.42 ± 37.62 | 125.75 ± 25.49 | ≤0.001 (HS) |
| Total WBCs (×103/μL) | 7.86 ± 2.59 | 5.18 ± 0.76 | ≤0.05 (S) |
| Neutrophils (%) | 57.22 ± 2.27 | 47.81 ± 6.17 | ≤0.001 (HS) |
| Eosinophils (%) | 5.1 ± 0.16 | 5.08 ± 0.17 | NS |
| Lymphocytes (%) | 36.63 ± 6.14 | 45.02 ± 2.64 | ≤0.001 (HS) |
| Platelets (×103/μL) | 264.42 ± 72.30 | 215.10 ± 25.38 | ≤0.001 (HS) |
| NLR | 1.61 ± 0.30 | 1.07 ± 0.16 | ≤0.001 (HS) |
| RBCs (×106/µL) | 4.54 ± 0.56 | 5.09 ± 0.64 | ≤0.05 (S) |
| Hb (g/dL) | 11.98 ± 1.78 | 13.25 ± 0.9 | ≤0.05 (S) |
| HCT (%) | 36.25 ± 5.44 | 40.92 ± 2.21 | ≤0.05 (S) |
| MCV (fL) | 83.79 ± 5.34 | 81.35 ± 3.47 | NS |
| MCH (pg) | 30.40 ± 3.46 | 27.21 ± 2.82 | ≤0.05 (S) |
| MCHC (g/dL) | 34.00 ± 1.31 | 30.12 ± 1.75 | ≤0.05 (S) |
ACE, angiotensin converting enzyme; Hb, hemoglobin; HCT, haematocrit; HS, highly significant; IL-6, interleukin-6; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; MCV, mean corpuscular volume; NLR, neutrophil-to-lymphocyte ratio; NS, nonsignificant; RBCs, red blood cells; S, significant; WBCs, white blood cells. * Mean ± standard error of the mean.